The cQrex® GQ effect: Boosting viral vector yield and quality in HEK-based AAV-production
Adeno-associated virus (AAV) vectors are a platform technology for gene therapies. Prominent examples authorized for marketing in Europe and the U.S. include Luxturna® and Zolgensma® which are based on AAV2 and AAV9 respectively. For AAV ... Continued
